Become a Member

Comment Subscriptions

You can follow the discussion on Microblog: Cambridge Massachussets small cap biotech company called EDITAS. Drug : AGN-151587 FDA fast track ref EDIT-101 : cure genetic blindness LCA10 using Crispr Genome editing tech without having to leave a comment. Just enter your email address in the form here below and you're all set.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info